Agilon Health (AGL)
(Delayed Data from NYSE)
$0.95 USD
-0.07 (-7.20%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $0.94 -0.01 (-0.70%) 7:58 PM ET
5-Strong Sell of 5 5
F Value A Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AGL 0.95 -0.07(-7.20%)
Will AGL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGL
New Strong Sell Stocks for October 8th
New Strong Sell Stocks for October 1st
AGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for August 20th
Here's What Key Metrics Tell Us About Agilon (AGL) Q2 Earnings
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
Other News for AGL
Is AGL gaining bearish strength? 180 Bearish Setup shows up after plummeting 6.42%
AGL forms Pocket Pivot on October 8
Evercore ISI Sticks to Its Hold Rating for Agilon Health (AGL)
AGL Fell Below 20 Day Moving Average on October 7
ANGLE plc Announces Strategic Shift and Name Change to CelLBxHealth